WTVM: 1 dead in Victory Dr. shooting near Grifols Talecris Plasma Resources in Columbus
1 dead in Victory Dr. shooting near Grifols Talecris Plasma Resources in Columbus
Grifols, a Spanish producer of plasma protein therapies, has agreed to acquire U.S.-based Talecris for about $3.4 billion. Talecris, a former Bayer business that also develops therapies from blood ...
FiercePharma: Grifols to Acquire Talecris Biotherapeutics Creating a World Leading Provider of Life-Saving Plasma Protein Therapies
- The combination of Grifols and Talecris will create a diversified, global provider of life-saving and life enhancing plasma protein therapeutics built on the strong global presence of Grifols and ...
Grifols to Acquire Talecris Biotherapeutics Creating a World Leading Provider of Life-Saving Plasma Protein Therapies
WRAL TechWire: Shares in Grifols, which bought RTP-based Talecris, soar as plasma prices surge
Shares in Grifols, which bought RTP-based Talecris, soar as plasma prices surge
RESEARCH TRIANGLE PARK, N.C. -- Spanish health care company Grifols plans to expand in the U.S. with the $3.4 billion purchase of plasma company Talecris Biotherapeutics. Talecris develops treatments ...
MADRID (Reuters) - Spain's Grifols has agreed to buy U.S.-based Talecris Biotherapeutics , which makes plasma-based protein medicines, for $3.4 billion in a bold move to expand its business in ...
Grifols SA, Europe’s largest maker of blood-plasma products, agreed to buy Talecris Biotherapeutics Holdings Corp. for about $3 billion in cash and stock to expand its share to almost a third of the U ...
Firms claim merger will enhance global plasma proteins business and provide new pipeline. Plasma protein therapeutics group Grifols is to acquire biotherapeutics firm Talecris for $3.4 billion worth ...